Companies: 10,795·Total market cap: $144.5T
Scholar Rock Holding Corporation

Scholar Rock Holding Corporation

SRRKNASDAQHealthcare● Active
$43.80
$-0.50(-1.13%)
Market Cap$5.2B
P/E Ratio
52W High$52.185
52W Low$27.07

Scholar Rock Holding Corporation (SRRK) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · SRRK · as of Sep 30, 2025

Ownership Breakdown

Institutions 96.81%
Insiders 19.56%
Public 0%

272

Institutional Holders

▲ 23 vs Q2

$5.40B

Total Inst. Value

▲ $1.51B vs Q2

119.83M

Shares Outstanding

freeFloat 80.44%

116.01M

13F Shares Held

▲ 6.23M vs Q2

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

SRRK largest shareholders · institutional ownership

Q3 2025 · SEC 13F

Showing top 10 holders

HolderShares% OwnedWeightValueReportedChange

FMR LLC

biological products, (no diagnostic substances)

14.01M12.43%

12.43%

$521.81BNov 13, 2025 177.2K

SIREN, L.L.C.

biological products, (no diagnostic substances)

9.25M8.21%

8.21%

$344.47BNov 13, 2025— held

PRICE T ROWE ASSOCIATES INC /MD/

biological products, (no diagnostic substances)

6.88M6.11%

6.11%

$256.33BNov 14, 2025 1.88M

BLACKROCK, INC.

biological products, (no diagnostic substances)

6.76M6.00%

6.00%

$251.75BNov 12, 2025 64.3K

SAMSARA BIOCAPITAL, LLC

biological products, (no diagnostic substances)

5.61M4.98%

4.98%

$209.02BNov 14, 2025— held

VANGUARD GROUP INC

biological products, (no diagnostic substances)

4.91M4.36%

4.36%

$183.03BNov 7, 2025 53.3K

WELLINGTON MANAGEMENT GROUP LLP

biological products, (no diagnostic substances)

4.55M4.03%

4.03%

$169.29BNov 14, 2025 2.52M

REDMILE GROUP, LLC

biological products, (no diagnostic substances)

3.90M3.46%

3.46%

$145.40BNov 14, 2025 24.6K

STATE STREET CORP

biological products, (no diagnostic substances)

3.76M3.34%

3.34%

$140.14BNov 14, 2025 688.8K

BELLEVUE GROUP AG

biological products, (no diagnostic substances)

3.24M2.88%

2.88%

$120.83BNov 14, 2025 297.2K

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q3 2025 vs prior quarter

Q3 2025

Net institutional sentimentBullish — more buying than selling

30

Increased

+12.80M shares

2

New Positions

first time holders

11

Decreased

−4.17M shares

0

Sold Out

fully exited

Net shares change (top 50)

+8.63M

+12.80M / −4.17M

Net new holders

+21

2 new / 0 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

SRRK insider trading · insider activity

Source: SEC Form 4

4

Buy transactions

8

Sell transactions

0.50

Buy/Sell ratio

$0M

Total disposed

Recent Insider Transactions

Showing 10 most recent · Common Stock only

Name · RoleDateTypeSharesPriceValueAfter Trans.Filing

FLIER JEFFREY S.

director

Jun 4, 2026Award6,83930.9KForm 4 ↗

FLIER JEFFREY S.

director

Jun 4, 2026Award4,310$45.33$195.4K4.3KForm 4 ↗

Reed Joshua

director

Jun 4, 2026Award6,83922.6KForm 4 ↗

Reed Joshua

director

Jun 4, 2026Award4,310$45.33$195.4K4.3KForm 4 ↗

Brudnick Richard

director

Jun 4, 2026Award6,83921.9KForm 4 ↗

Brudnick Richard

director

Jun 4, 2026Award4,310$45.33$195.4K4.3KForm 4 ↗

Burow Kristina

director

Jun 4, 2026Award6,839117.7KForm 4 ↗

Burow Kristina

director

Jun 4, 2026Award4,310$45.33$195.4K4.3KForm 4 ↗

Gilman Michael

director

Jun 4, 2026Award6,83962.1KForm 4 ↗

Gilman Michael

director

Jun 4, 2026Award4,310$45.33$195.4K4.3KForm 4 ↗

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

Scholar Rock Holding Corporation (SRRK) is primarily owned by institutional investors, who hold approximately 96.8% of total shares outstanding. Company insiders own approximately 19.56%, while retail and public investors account for the remaining 0.00%.

The largest institutional shareholder of Scholar Rock Holding Corporation is FMR LLC, holding approximately 14.01 million shares — equal to 12.43% of outstanding shares — as of September 30, 2025.

A total of 272 institutional investors currently hold SRRK stock, with a combined institutional value of approximately $5.40 billion as of the most recent 13F filing period.

Frequently asked questions

SRRK ownership

Scholar Rock Holding Corporation (SRRK) is primarily owned by institutional investors, who hold approximately 96.8% of shares. The largest shareholder is FMR LLC with a 12.43% stake. Company insiders hold 19.56%. Data sourced from SEC Form 13F as of September 30, 2025.

who owns SRRK stockSRRK ownership structureSEC Form 13F institutional holdingsSRRK float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of September 30, 2025